INmune Bio Co-Founders to Present at World Immunotherapy Congress during the Festival of Biologics San Diego
26. Februar 2019 09:30 ET
|
INmune Bio, Inc.
Presentations to address the role of the innate immune system in treating cancer LA JOLLA, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused...
INmune Bio Awarded a $1 Million Grant for the Development of XPro1595 for the treatment of Alzheimer’s Disease
11. Februar 2019 08:00 ET
|
INmune Bio, Inc.
The Alzheimer’s Association awarded INmune Bio the Part the Cloud to RESCUE grant to target neuroinflammation in Alzheimer’s Disease LA JOLLA, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- INmune...
INmune Bio to Present at BIO CEO & Investor Conference
06. Februar 2019 09:00 ET
|
INmune Bio, Inc.
LA JOLLA, CA, Feb. 06, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (Nasdaq: INMB) (“INmune” or the “Company”), an immunotherapy company focused on developing therapies that harness the patient’s...
INmune Bio, Inc. Announces Pricing of Initial Public Offering
15. Januar 2019 15:00 ET
|
INmune Bio, Inc.
LA JOLLA, CA, Jan. 15, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (“INmune” or the “Company”), an immunotherapy company focused on developing therapies that harness the patient’s innate immune...
INmune Bio Granted Phase I Clinical Trial Authorization of Lead Product INKmune™ in Refractory and Recurrent Ovarian Cancer Patients
19. Dezember 2018 08:00 ET
|
INmune Bio, Inc.
LA JOLLA, California, Dec. 19, 2018 (GLOBE NEWSWIRE) -- INmune Bio Inc., an immunotherapy company developing treatments to reprogram the innate immune system to fight disease, announced today that...
INmune Bio Announces Publication of Myeloid-Derived Suppressor Cells (MDSC) Report in the Cell’s Trends in Pharmacological Sciences Journal
07. Dezember 2018 09:00 ET
|
INmune Bio, Inc.
Manuscript highlights the vital role of MDSC in the tumor microenvironment (TME) LA JOLLA, Calif.,, Dec. 07, 2018 (GLOBE NEWSWIRE) -- INmune Bio Inc., an immunotherapy company developing...
INmune Nominated for Buzz of Bio Award at 2019 CEO & Investor Conference
04. Dezember 2018 08:30 ET
|
INmune Bio, Inc.
-Voting begins today: Click here to cast your vote- LA JOLLA, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- INmune Bio, Inc., an immunotherapy company focused on developing therapies that harness...